Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Explore this paper's citation graph
Summary
Postoperative cisplatin-based chemotherapy significantly improves survival in patients with non-small-cell lung cancer (NSCLC).
- Type
- article
- Published
- 2008-07-20
- Cited by
- 2,415
- References
- 38
- Access
- Open access
- OpenAlex
- https://openalex.org/W2104504726
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:39658042
Keywords
Medicine, Vinorelbine, Internal medicine, Vinca, Chemotherapy
References
- Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis.
- Vascular toxicity associated with antineoplastic agents.
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group.
- Beta blockade during and after myocardial infarction: an overview of the randomized trials.
- A note on quantifying follow-up in studies of failure time.
- Cardiotoxicity of cytotoxic drugs.
- Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
- Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
- DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
- Adjuvant chemotherapy in stage IB non-small cell lung cancer
- A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
- Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
- 6516 ORAL Venous thromboembolism (VTE) and non-small cell lung cancer (NSCLC): a pooled analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trials
- Acute cerebral infarction during combination chemotherapy with s-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach.
- Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis.
- Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.
- Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
- Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
- Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
- Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Cited by
- Behandlung des nichtkleinzelligen Lungenkarzinoms
- Gene expression profiling and non-small-cell lung cancer: where are we now?
- High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
- [Resected non-small cell bronchogenic carcinoma stage pIIIA-N2. Which patients will benefit most from adjuvant therapy?].
- Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification
- "When Roscius was an actor in Rome-" care for the elderly with N2-positive non-small-cell lung cancer.
- Systemic and targeted therapies for early-stage lung cancer.
- Pemetrexed-Carboplatin Adjuvant Chemotherapy With or Without Gefitinib in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Harbouring EGFR Mutations: A Randomized, Phase II Study
- A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer.
- Prediction of Early Response to Chemotherapy in Lung Cancer by Using Diffusion-Weighted MR Imaging
- Ⅰb期肺癌术后辅助化疗高风险因素分析
- Recent evidence, advances, and current practices in surgical treatment of lung cancer.
- Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery
- Predicting lung cancer recurrence from circulating tumour DNA. Commentary on 'Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution'
- Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
- Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma
- Targeted therapies for advanced non-small cell lung cancer
- Adjuvant TKIs: still an optimal choice.
- Terapêutica após progressão do carcinoma do pulmão de não pequenas células precoce ou localmente avançado tratado com quimioterapia
- Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.
Related papers
- Vinorelbine (Navelbine): a third-generation vinca alkaloid.
- Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
- Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
- Pharmacokinetics and metabolism of vinca alkaloids.
- A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
- Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography.
- Pharmacological Activity of Vinca Alkaloids
- [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
- Vinca Alkaloids
- Experimental in vivo cross-resistance of vinca alkaloid drugs